Literature DB >> 4943812

New approaches to chemotherapy with folate antagonists: use of leucovorin "rescue" and enzymic folate depletion.

J R Bertino, M Levitt, J L McCullough, B Chabner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4943812

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Carboxypeptidase displaying differential velocity in hydrolysis of methotrexate, 5-methyltetrahydrofolic acid, and leucovorin.

Authors:  A M Albrecht; E Boldizsar; D J Hutchison
Journal:  J Bacteriol       Date:  1978-05       Impact factor: 3.490

2.  Pharmacokinetic characterization of extracorporeal therapy.

Authors:  H Pedersen; C Horváth
Journal:  J Pharmacokinet Biopharm       Date:  1982-08

3.  Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions.

Authors:  S B Howell; B B Chu; W E Wung; B M Metha; J Mendelsohn
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

4.  [Suppression of cytostatic effect of amethopterin (methotrexate) with methyltetrahydrofolic acid].

Authors:  H Sauer; L Jaenicke
Journal:  Blut       Date:  1974-05

5.  The potential of carboxypeptidase G2: antibody conjugates as anti-tumour agents. II. In vivo localising and clearance properties in a choriocarcinoma model.

Authors:  R G Melton; F Searle; R F Sherwood; K D Bagshawe; J A Boden
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

6.  Glucarpidase to combat toxic levels of methotrexate in patients.

Authors:  Jacalyn M Green
Journal:  Ther Clin Risk Manag       Date:  2012-11-22       Impact factor: 2.423
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.